Healthcare

Entero Healthcare Solutions Limited

Who owns Entero Healthcare Solutions Limited?

The promoter group held 52.40% of Entero Healthcare at 30 September 2026, led by Orbimed Asia III Mauritius Limited (38.00%). Public shareholders held 47.60%.3 Filed categories do not identify every ultimate beneficial owner.

What the company does

Distributes pharmaceutical and health-care products to pharmacies and hospitals.

Official website
www.enterohealthcare.com
Headquarters
Faridabad, Haryana (registered office city)
Registered office
Plot No. I-35 Building - B, Industrial Area Phase -I, 13/7 Mathura Road,, Faridabad, 121003, Haryana, India Address source
Country of incorporation
India
Corporate Identity Number
L74999HR2018PLC0722042
Incorporated
2018 · Public limited company
LEI
335800JIMRC57GVQFT506
Exchange identifiers
NSE ENTERO · BSE 544122 · ISIN INE0106010162
Exchange listing dates
NSE 2024-02-167 · BSE 2024-02-162 (IPO offer price not verified in this release)
Largest reported categoryAs of 2026-09-30
52.40%
Promoter and promoter group

A shareholder category in this filed snapshot; it is not an individual beneficial owner.

Explore disclosed holdings
Disclosure as of
CoverageAggregate shareholder categories
Indexed entries2

What the disclosure establishes

Filed categories are not individual beneficial owners. Promoter and public categories do not, by themselves, establish ultimate economic ownership or voting control. Named holders below are subsets of those categories.

Scope. Shareholding pattern dated 30 September 2026. A = promoter group; B = public; C2 = employee trusts. Percentages use the (A+B+C2) denominator. Categories are not identified people and are not evidence of ultimate beneficial control.

Ownership composition

Aggregate shareholder categories; not individual beneficial owners.

Promoter and promoter group 52.40%Public shareholders 47.60%

Aggregate categories in this record

3 categories

Shareholder categoryReported holdingSource
Promoter and promoter group52.40%Original disclosure
Public shareholders47.60%Original disclosure
Shares held by employee trusts (C2)0.00% reported as zeroOriginal disclosure

Named shareholders in the filing

11 named

Names exactly as filed in Table II (promoter group) and Table III (public holders above 1%). They are part of the categories above; do not add them to the category totals.

Name as filedFiling tableHolding
Orbimed Asia III Mauritius LimitedPromoter group (Table II) · Any Other (specify)38.00%4
Prabhat AgrawalPromoter group (Table II) · Individuals/Hindu undivided Family9.26%4
Prem SethiPromoter group (Table II) · Individuals/Hindu undivided Family5.15%4
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUNDPublic, above 1% (Table III) · Mutual Funds3.19%4
INVESCO INDIA CONTRA FUNDPublic, above 1% (Table III) · Mutual Funds3.19%4
SURBHI SINGH(PRASID UNO FAMILY TRUST)Public, above 1% (Table III) · Any Other (specify)3.05%4
3P INDIA EQUITY FUND 1Public, above 1% (Table III) · Alternate Investment Funds3.03%4
BANK OF INDIA FLEXI CAP FUNDPublic, above 1% (Table III) · Mutual Funds2.40%4
CIF III SCHEME IPublic, above 1% (Table III) · Alternate Investment Funds1.53%4
3P INDIA EQUITY FUND 1MPublic, above 1% (Table III) · Alternate Investment Funds1.18%4
AJAY KUMAR AGGARWALPublic, above 1% (Table III) · Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs1.01%4

Inside the public category

Table III sub-totals

Sub-categoryHolding
Domestic institutions (B1)21.16%
Foreign institutions, incl. FPIs (B2)5.77%
Central and state governments (B3)0.00%
Non-institutional shareholders (B4)20.67%

Sub-totals of the 47.60% public category in the same filing.4

Dated disclosures in the Atlas

2 observations

As ofPromoter (A)Public (B)Employee trusts (C2)
52.40%47.60%0.00%3
52.40%47.60%0.00%8

Data, history and downloads

Machine-readable record

From → toPromoterPublicEmployee trusts
2026-06-30 → 2026-09-300.00 pp0.00 pp0.00 pp

Differences between the filed category percentages of consecutive dated disclosures, in percentage points. Earlier disclosures are kept unchanged.

Original exchange disclosures are linked above and remain the authoritative record. The files below are The Raisina Post’s compilation of them: JSON · CSV · Markdown. Last modified 2026-10-21. See the dataset method and limitations.

Compare with other companies in Healthcare.

Original filing and record context

Original source
NSE XBRL shareholding pattern (SEBI LODR Reg. 31) for ENTERO · 30 September 2026 · Table I summary
Observation date
2026-09-30
Filed with the exchange
2026-10-21
Verification
Category totals match in the BSE and NSE copies of this filing
Disclosure type
Aggregate categories, with named holders shown separately
Atlas entity ID
RPA-000417
Atlas verification date
2026-11-22

Percentages are copied from the filing without recalculation and use the (A+B+C2) denominator. Compare the original document before using these figures for investment, procurement or governance decisions.

References

  1. Official company website (as listed in the BSE company record)
  2. BSE company record: registered office, CIN, ISIN, industry
  3. NSE XBRL filing: shareholding pattern dated 30 September 2026, Table I
  4. BSE shareholding pattern: Tables II and III (named holders)
  5. NSE shareholding-pattern filing index for ENTERO
  6. GLEIF LEI record
  7. NSE equity master list (listing date)
  8. Shareholding pattern dated 30 June 2026

Questions about this company

From the dated Atlas record and official sources.